Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$357K Sell
5,466
-13,426
-71% -$982K 0.03% 419
2025
Q4
$1.52M Buy
18,892
+4,600
+32% +$370K 0.21% 194
2025
Q3
$1.17M Buy
14,292
+4,232
+42% +$367K 0.18% 233
2025
Q2
$918K Buy
+10,060
New +$899K 0.14% 279
2024
Q2
Sell
-8,676
Closed -$784K 334
2024
Q1
$784K Sell
8,676
-4,158
-32% -$379K 0.7% 15
2023
Q4
$1.13M Sell
12,834
-4,063
-24% -$339K 0.32% 95
2023
Q3
$1.43M Buy
+16,897
New +$1.53M 0.42% 47
2022
Q2
Sell
-6,333
Closed -$520K 243
2022
Q1
$520K Sell
6,333
-526
-8% -$41.2K 0.27% 154
2021
Q4
$514K Buy
+6,859
New +$515K 0.4% 95

Other funds holding DOX

Oak Thistle LLC's DOX Position: Q1 2026 in Review

Oak Thistle LLC reduced its Amdocs (DOX) stake by 71% in Q1 2026, selling an estimated $982K and leaving 5,466 shares worth $357K. The position accounts for 0.03% of the portfolio, ranked #419.

Oak Thistle LLC first reported a position in DOX in Q4 2021 and has held it in 9 quarters since. The position peaked at $1.52M in Q4 2025. 473 funds tracked by Wall St. Rank hold DOX as of Q1 2026.

  • Oak Thistle LLC held 5,466 shares of Amdocs worth $357K as of Q1 2026.
  • Oak Thistle LLC sold 13,426 Amdocs shares in Q1 2026, an estimated $982K.
  • Amdocs made up 0.03% of Oak Thistle LLC's portfolio in Q1 2026, its #419 holding.
  • Oak Thistle LLC first reported a position in Amdocs in Q4 2021 and has held it in 9 quarters since.
  • Oak Thistle LLC's Amdocs position peaked at $1.52M in Q4 2025.
  • 473 funds tracked by Wall St. Rank held Amdocs as of Q1 2026.

Based on Oak Thistle LLC's 13F filing for Q1 2026, filed 13 Apr 2026.